NICE and new: appraising innovation

被引：32

作者：

Ferner, Robin E. ^{[2
]}

Hughes, Dyfrig A. ^{[1
]}

Aronson, Jeffrey K. ^{[3
]}

机构：

[1] Bangor Univ, Inst Med & Social Care Res, Ctr Econ & Policy Hlth, Bangor LL57 1UT, Gwynedd, Wales

[2] City Hosp, W Midlands Ctr Adverse Drug React, Birmingham B18 7QH, W Midlands, England

[3] Dept Primary Hlth Care, Oxford OX3 7LF, England

来源：

BMJ-BRITISH MEDICAL JOURNAL | 2010年 / 340卷

关键词：

D O I：

10.1136/bmj.b5493

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：5

共 16 条

[1]

[Anonymous], 1988, BRIT MED J, V296, P320

[2] Something New Every Day Defining Innovation and Innovativeness in Drug Therapy [J].

Aronson, Jeffrey K. .

JOURNAL OF AMBULATORY CARE MANAGEMENT, 2008, 31 (01) :65-68

[3] Medicines regulation and clinical pharmacology [J].

Baber, NS ;

Ritter, JM ;

Aronson, JK .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2004, 58 (06) :569-570

[4] Why is Exubera being withdrawn? [J].

Bailey, Clifford J. ;

Barnett, Anthony H. .

BRITISH MEDICAL JOURNAL, 2007, 335 (7630) :1156-1156

[5]

*DEP INN U SKILLS, 2008, PROC INN INN PROC

[6] Economic evaluation of health interventions [J].

Drummond, Michael ;

Weatherly, Helen ;

Ferguson, Brian .

BRITISH MEDICAL JOURNAL, 2008, 337 (7673)

[7]

Kennedy I., 2009, Appraising the value of innovation and other benefits

[8] The NICE cost-effectiveness threshold - What it is and what that means [J].

McCabe, Christopher ;

Claxton, Karl ;

Culyer, Anthony J. .

PHARMACOECONOMICS, 2008, 26 (09) :733-744

[9]

*NIH CLIN EXC, 2008, GUID METH TECHN APPR

[10]

*NIH CLIN EXC, 2009, RESP SIR I KENN REP

← 1 2 →